Hydrochloric Acid → 4-[4-((1R,2R)-2-amino-cyclopentyloxy)-5-trifluoromethyl-pyrimidin-2-ylamino]-3-methoxy-N-(1-methyl-piperidin-4-yl)-benzamide
반응식
[NH2:1][C@@H:2]1[CH2:6][CH2:5][CH2:4][C@H:3]1[OH:7].Cl.[H-].[Na+].Cl[C:12]1[C:17]([C:18]([F:21])([F:20])[F:19])=[CH:16][N:15]=[C:14]([NH:22][C:23]2[CH:38]=[CH:37][C:26]([C:27]([NH:29][CH:30]3[CH2:35][CH2:34][N:33]([CH3:36])[CH2:32][CH2:31]3)=[O:28])=[CH:25][C:24]=2[O:39][CH3:40])[N:13]=1>O1CCOCC1.O>[NH2:1][C@@H:2]1[CH2:6][CH2:5][CH2:4][C@H:3]1[O:7][C:16]1[C:17]([C:18]([F:19])([F:21])[F:20])=[CH:12][N:13]=[C:14]([NH:22][C:23]2[CH:38]=[CH:37][C:26]([C:27]([NH:29][CH:30]3[CH2:31][CH2:32][N:33]([CH3:36])[CH2:34][CH2:35]3)=[O:28])=[CH:25][C:24]=2[O:39][CH3:40])[N:15]=1참가 물질
7
반응물 4
생성물 1
시약·촉매·용매 2
실험 절차
(R,R)-2-aminocyclopentanol×HCl (155 mg) is added to a suspension of NaH (135.2 mg) in dioxane (0.75 mL) and stirred for 30 min at RT. Then 4-(4-chloro-5-trifluoromethyl-pyrimidin-2-ylamino)-3-methoxy-N-(1-methyl-piperidin-4-yl)-benzamide (250 mg) is added. After 18 h, H2O (50 mL) is added. The precipitate formed is filtered off, washed with H2O, dissolved in CH2Cl2 and extracted with aqueous KHSO4 solution (10%). The aqueous phase is made basic again with K2CO3 and extracted with CH2Cl2. The organic phase is dried on magnesium sulphate, filtered to remove the desiccant and the solvent is eliminated in vacuo.
후처리
- waitAfter 18 h
- customThe precipitate formed
- filtrationis filtered off
- washwashed with H2O
- dissolutiondissolved in CH2Cl2
- extractionextracted with aqueous KHSO4 solution (10%)
- extractionextracted with CH2Cl2
- customThe organic phase is dried on magnesium sulphate
- filtrationfiltered
- customto remove the desiccant
출처 및 근거
- ORD 기록
- ord-0188558b097749a9afef32a261f7895e
- 출처 데이터셋
- uspto-grants-2013_06
- 특허 번호
- US08466155B2
반응 노트
불러오는 중…